Boris Sepesi MD FACS

70 posts

Boris Sepesi MD FACS banner
Boris Sepesi MD FACS

Boris Sepesi MD FACS

@BorisSepesi

Thoracic Surgery, Lung Cancer, Esophageal Cancer, Mesothelioma

Katılım Eylül 2022
177 Takip Edilen260 Takipçiler
Boris Sepesi MD FACS retweetledi
Vala Afshar
Vala Afshar@ValaAfshar·
Life lessons from @rogerfederer (must watch) 1 Effortless is a myth 2 Belief in yourself has to be earned 3 Grit > Gift 4 Discipline is talent 5 Trust and loving the process is talent 6 You can do your best and still lose 7 Life is bigger than the court
English
219
6.7K
28.7K
2.7M
Boris Sepesi MD FACS
Boris Sepesi MD FACS@BorisSepesi·
@ShandaBlackmon It is about exposure and how much fun it is to dissect those nodes versus how much of a chore it is. Robotics allows visualization exposure and fine dissection. Also the pace of dissection and comfort is different. I believe these are purely the factors. VATS requires more grit.
English
0
0
5
128
Shanda Blackmon, MD, MPH
Shanda Blackmon, MD, MPH@ShandaBlackmon·
We have to do a better job as a specialty of MLND. VATS, robot, open all need attention to detail. The approach does not guide or determine the lymphadenectomy- the surgeon does.
Ory Wiesel@OryWiesel

More than meets the eye... impotency of surgeon experience & lymphadenectomy in Thoracic surgical oncology @JamieTankel @SurgJournal @SWexner @ElliotServaisMD @BrianMitzman @maraantonoff @ShandaBlackmon @BMBurtMD @BrendonStilesMD authors.elsevier.com/a/1iiwx90L%7E-…

English
3
1
12
4.3K
donington
donington@jdoningtonmd·
Amazing start to day hiking beautiful Tubb’s Hill trail. Excited to be back in scenic Coeur D’Alene for #WTSA2023
donington tweet mediadonington tweet mediadonington tweet mediadonington tweet media
English
1
0
16
1.3K
Boris Sepesi MD FACS retweetledi
Sam Sater, MD
Sam Sater, MD@HSaterMD·
Dr Tina Cascone @MDAndersonNews presented an amazing review of NIO in lung cancer #LCSM and highlighted NeoCoast Study. She also called for reverse translation @sitcancer #SITC22
Sam Sater, MD tweet mediaSam Sater, MD tweet mediaSam Sater, MD tweet mediaSam Sater, MD tweet media
Boston, MA 🇺🇸 English
0
5
14
0
Boris Sepesi MD FACS retweetledi
Reza Mehran, MD
Reza Mehran, MD@rjmehran·
MD Anderson was honored with the presence of Dr. David Harpole from Duke University for the @MDAndersonNews 2022 Jack A. Roth Distinguished Lecturer in the Thoracic Surgery Research. In the process he also became an honorary Texan!
Reza Mehran, MD tweet mediaReza Mehran, MD tweet media
English
0
8
39
0
Boris Sepesi MD FACS
Boris Sepesi MD FACS@BorisSepesi·
@mtmdphd @JackWestMD @ADesaiMD @AnaVManana @JAMAOnc So the question really is whether it is easier to recover from neoadjuvant therapy to proceed with surgery or recover from surgery to proceed with adjuvant therapy. Historically ~90% proceeded to surgery after chemo but only ~60% received adjuvant chemo. New era now.
English
2
0
6
0
Boris Sepesi MD FACS
Boris Sepesi MD FACS@BorisSepesi·
@BrendonStilesMD @DoctorJSpicer @cusm_muhc North Star and Bright Star results with shed some light on this in stage IV. It is not a comparison between surgery and RT. Both are valid LCT modalities. Benefit of surgery following TKI is getting final path report of response. All therapies complement each other over time.
English
0
1
6
0
Brendon Stiles
Brendon Stiles@BrendonStilesMD·
@DoctorJSpicer @cusm_muhc Agree with avoiding large volume radiation fields. Makes sense to start with targeted therapy and then resect local and regional disease. I don’t have data to support, but suspect strongly that surgery is better than RT for ALK/EGFR oligo disease if can be done safely.
English
1
1
8
0
Jonathan Spicer MD PhD
Jonathan Spicer MD PhD@DoctorJSpicer·
In this space, we @cusm_muhc have advocated for off protocol neoadj TKI for ALK and EGFR operable N2 rather than CRT. Many of these pts are young and it seems unnecessary to radiate their mediastinum if it can be avoided. Luckily, we now have NeoADAURA to do this on protocol!
Lecia Sequist, MD, MPH, FASCO@LeciaSequist

@DrewMoghanaki @SBroderickMD @DoctorJSpicer @DocMCotant @FordePatrick @HenningWillers Every patient must be considered individually of course but we are primarily doing CM816 if patients are eligible. One key group that we prefer CRT is EGFR and ALK pts, who were not included in CM816. More data on how to use neoadj targeted TKIs is needed for this group!

English
4
3
17
0

Keşfet

@rogerfederer @ShandaBlackmon @jdoningtonmd @rjmehran @maraantonoff @MDAndersonNews @KGMitchellMD @DavidNelsonMD